PET/CT scans
Sponsors
Memorial Sloan Kettering Cancer Center, University Health Network, Toronto, NYU Langone Health, Zhongnan Hospital, Peking University People's Hospital
Conditions
Breast Cancer, MetastaticCD34 Selected Peripheral Blood Stem Cell GraftHead and Neck CancerHistologically-confirmed MalignanciesLung CancerMalignant NeoplasmMultiple MyelomaNasopharyngeal Cancer
Phase 1
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Active, not recruitingNCT03631017
Start: 2018-08-10End: 2027-08-01Updated: 2026-09-08
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
CompletedNCT03665155
Start: 2018-09-05End: 2020-04-20Updated: 2021-07-30
Unknown Phase
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
WithdrawnNCT02139150
Start: 2014-05-31End: 2020-05-31Updated: 2019-09-17
A Study to Assess Thymic Function Using PET/CT and MRI
CompletedNCT02909075
Start: 2016-08-31End: 2020-01-31Updated: 2020-01-27
PET CT Re-Planning NSCLC (4DCT-PET)
CompletedNCT03403127
Start: 2008-05-20End: 2020-04-28Updated: 2020-08-14
Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
CompletedNCT03656250
Start: 2017-11-18End: 2018-11-19Updated: 2020-10-19
Integrin αvβ6-targeted PET in Malignant Tumors
RecruitingNCT05835570
Start: 2023-01-01End: 2025-12-30Target: 200Updated: 2025-04-30
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
RecruitingNCT07487883
Start: 2026-03-18End: 2027-07-30Target: 80Updated: 2026-04-02
FAP-targeted PET/NIR in Lung Malignant Tumors
RecruitingNCT07498933
Start: 2025-06-03End: 2027-12-31Target: 200Updated: 2026-04-01